Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis

This publication has 37 references indexed in Scilit:

• 2001 Warkany lecture: To die or not to die, the role of apoptosis in normal and abnormal mammalian development
  Teratology, 2002
• Stat Bite: Estimated Cervical Cancer Mortality in Selected Countries, 2000
  JNCI Journal of the National Cancer Institute, 2002
• Up-regulation of Fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance
  Hepatology, 2000
• True
  British Journal of Cancer, 2000
• Smoking, diet, pregnancy and oral contraceptive use as risk factors for cervical intra-epithelial neoplasia in relation to human papillomavirus infection
  British Journal of Cancer, 2000
• Cervical cancer risk: is there a genetic component?
  Molecular Medicine Today, 2000
• Type-Specific Persistence of Human Papillomavirus DNA before the Development of Invasive Cervical Cancer
  New England Journal of Medicine, 1999
• Lymphocyte apoptosis induced by CD95 (APO–1/Fas) ligand–expressing tumor cells — A mechanism of immune evasion?
  Nature Medicine, 1996
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
  Science, 1995
• Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia
  British Journal of Cancer, 1994